MISSED OUT ON THE LATEST CLINICAL GUIDELINE ANNOUNCEMENTS?
No problem, we’ve got you covered! Here’s a list to all guidelines and FDA approvals that were published last month.
- Sleep-Related Infant Deaths: Updated 2022 Recommendations for Reducing Infant Deaths in the Sleep Environment
- Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
- Pharmacological Management of Irritable Bowel Syndrome With Diarrhea
- Pharmacological Management of Irritable Bowel Syndrome With Constipation
- Management of Metastatic Clear Cell Renal Cell Carcinoma
- Biomarkers for Systemic Therapy in Metastatic Breast Cancer
- Systemic Therapy for Melanoma
- Treatment of Visceral Leishmaniasis in HIV Co-Infected Patients in East Africa and South-East Asia
- Fortification of Wheat Flour with Vitamins and Minerals as a Public Health Strategy
EXCLUSIVE SOCIETY GUIDELINES AND MANY MORE!
Search, bookmark, add notes and create your personal clinical guideline library with your digital copy or one of our society and specialty subscription bundles.
JUNE 1, 2022 BEOVU
Treatment of diabetic macular edema (DME)
JUNE 6, 2022 RIABNI
In combination with methotrexate for adults with moderate to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies
JUNE 6, 2022 PRIORIX
For active immunization for the prevention of measles, mumps and rubella (MMR) in individuals 12 months of age and older
JUNE 7, 2022 DUPIEXENT
For children aged 6 months to 5 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable
JUNE 13, 2022 OLUMIANT
Treatment for adults with severe alopecia areata (AA)
JUNE 13, 2022 AMVUTTRA
Treatment of polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults
JUNE 13, 2022 CELLCEPT
Prophylaxis of organ rejection in pediatric recipients of allogenic heart and allogeneic liver transplants aged 3 months and older in combination with other immunosuppressants
JUNE 17, 2022 SKYRIZI
Treatment of moderately to severely active Crohn’s disease in adults
JUNE 17, 2022 IMCIVREE
For chronic weight management in adults and pediatric patients age 6 and older with obesity due to Bardet-Biedl Syndrome (BBS)
JUNE 22, 2022 VAXNEUVANCE
Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
JUNE 27, 2022 QSYMIA
For chronic weight management in pediatric patients 12 years and older who defined as having a body mass index (BMI) of 95th percentile or greater when standardized for age and sex
JUNE 27, 2022 BREYANZI
For the second-line treatment of adult patients with relapsed or refractory large B-cell lymphoma (r/r LBCL)
Copyright © 2022 Guideline Central, All rights reserved.